Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries (2015)
- Authors:
- USP affiliated authors: MESTRINER, FABIOLA LESLIE ANTUNES CARDOSO - FMRP ; RODRIGUES, JOSE ANTUNES - FMRP ; EVORA, PAULO ROBERTO BARBOSA - FMRP ; MORAES, LEONARDO RESSTEL BARBOSA - FMRP ; CARNEIRO, FERNANDO SILVA - FMRP ; PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2015.09.002
- Subjects: ANTIDEPRESSIVOS; ÓXIDO NÍTRICO; CANAIS IÔNICOS; POTÁSSIO; VASODILATAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 765, p. 375–383, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: unspecified-oa
-
ABNT
PEREIRA, Camila A. et al. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, v. 765, p. 375–383, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2015.09.002. Acesso em: 28 dez. 2025. -
APA
Pereira, C. A., Ferreira, N. dos S., Mestriner, F. L. A. C., Antunes-Rodrigues, J., Évora, P. R. B., Resstel, L. B. M., et al. (2015). Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries. European Journal of Pharmacology, 765, 375–383. doi:10.1016/j.ejphar.2015.09.002 -
NLM
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002 -
Vancouver
Pereira CA, Ferreira N dos S, Mestriner FLAC, Antunes-Rodrigues J, Évora PRB, Resstel LBM, Carneiro FS, Passaglia R de CAT. Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries [Internet]. European Journal of Pharmacology. 2015 ; 765 375–383.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.ejphar.2015.09.002 - Chronic treatment with fluoxetine increases relaxation of rat resistance mesenteric arteries via Atp-sensitive potassium channels activation
- Chronic treatment with fluoxetine increases relaxation of rat resistance mesenteric arteries via Atp-sensitive potassium channels activation
- Chronic treatment with fluoxetine modulates vascular adrenergic responses by inhibition of pre- and post synaptic mechanisms
- Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation
- NLRP3 activation contributes to endothelin-1-induced erectile dysfunction
- Mesenteric arteries from stroke-prone spontaneously hypertensive rats exhibit an increase in nitric-oxide-dependent vasorelaxation
- Erectile dysfunction in heart failure rats is associated with increased neurogenic contractions in cavernous tissue and internal pudendal artery
- NACHT, LRR and PYD domains-containing protein 3(NLRP3) crucial role of the cavernous tissue tone modulation in mice
- O -linked N -acetyl-glucosamine deposition in placental proteins varies according to maternal glycemic levels
- O-Glycosylation with O-linked β-N-acetylglucosamine increases vascular contraction: possible modulatory role on Interleukin-10 signaling pathway
Informações sobre o DOI: 10.1016/j.ejphar.2015.09.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
